David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWCH
3026
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.72M | ﹤0.01% |
+67,682
| New | +$1.59M |
|
3027
American Vanguard Corp
AVD
$64.6M
| $1.71M | ﹤0.01% |
113,626
+92,761
| +445% | +$1.47M |
|
3028
Steris
STE
$22.8B
| $1.71M | ﹤0.01% |
8,362
-119,929
| -93% | -$25.7M |
|
|
GMDA
3029
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.71M | ﹤0.01% |
435,368
+295,928
| +212% | +$1.48M |
|
3030
Banco Macro
BMA
$4.93B
| $1.71M | ﹤0.01% |
100,337
-25,990
| -21% | -$411K |
|
3031
Tandem Diabetes Care
TNDM
$1.51B
| $1.7M | ﹤0.01% |
14,265
-929
| -6% | -$102K |
|
3032
Butterfly Network
BFLY
$2.43B
| $1.7M | ﹤0.01% |
+163,026
| New | +$1.88M |
|
3033
Prologis
PLD
$135B
| $1.7M | ﹤0.01% |
13,568
-104,859
| -89% | -$13.6M |
|
3034
CALL
Sprout Social
SPT
$670M
| $1.7M | ﹤0.01% |
13,900
+3,900
| +39% | +$424K |
|
|
HCII
3035
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $1.7M | ﹤0.01% |
173,869
+30,995
| +22% | +$302K |
|
3036
AGCO
AGCO
$7.76B
| $1.69M | ﹤0.01% |
13,803
+4,146
| +43% | +$542K |
|
3037
Covenant Logistics
CVLG
$912M
| $1.68M | ﹤0.01% |
121,694
-13,078
| -10% | -$146K |
|
|
MSAC
3038
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $1.68M | ﹤0.01% |
+172,065
| New | +$1.66M |
|
|
TUP
3039
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.68M | ﹤0.01% |
79,300
+60,000
| +311% | +$1.34M |
|
|
MZTI
3040
The Marzetti Company
MZTI
$3.06B
| $1.67M | ﹤0.01% |
9,885
+8,605
| +672% | +$1.59M |
|
|
MAGN
3041
Magnera Corp
MAGN
$442M
| $1.67M | ﹤0.01% |
9,089
-6,481
| -42% | -$1.26M |
|
|
HUGS
3042
DELISTED
USHG Acquisition Corp.
HUGS
| $1.66M | ﹤0.01% |
+171,378
| New | +$1.66M |
|
3043
CALL
Harley-Davidson
HOG
$2.9B
| $1.66M | ﹤0.01% |
45,400
-5,000
| -10% | -$202K |
|
|
BGFV
3044
DELISTED
Big 5 Sporting Goods
BGFV
| $1.66M | ﹤0.01% |
72,087
-37,430
| -34% | -$918K |
|
3045
Local Bounti
LOCL
$23.6M
| $1.66M | ﹤0.01% |
12,816
| – | – |
|
3046
MacroGenics
MGNX
$262M
| $1.65M | ﹤0.01% |
78,712
-48,932
| -38% | -$1.18M |
|
3047
Nuvation Bio
NUVB
$2.51B
| $1.65M | ﹤0.01% |
165,491
-3,424
| -2% | -$31K |
|
|
PAQC
3048
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
| $1.64M | ﹤0.01% |
+168,610
| New | +$1.63M |
|
3049
Bunge Global
BG
$21.4B
| $1.64M | ﹤0.01% |
20,162
+8,945
| +80% | +$690K |
|
|
SEMR
3050
DELISTED
Semrush
SEMR
| $1.64M | ﹤0.01% |
71,127
-2,784
| -4% | -$64.2K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.